IL15 and acute myeloid leukemia: Several clinical trials have shown good outcome and feasibility for the use of IL-15 with NK cells for several cancer types including acute myeloid leukemia, advanced non-small-cell lung cancer and pediatric refractory solid tumor [27,28,29,30].